Search Results 781-790 of 16881 for Amphotericin B
- To evaluate the safety profile of the combination with isatuximab administration from fixed volume (Part B). - To evaluate immunogenicity of SAR650984 in ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
There are no doctors whose last name begins with the letter B B; There are no ... Transplant Hepatologist. Phoenix, AZ. Areas of focus: Hepatitis C, Hepatitis B ...
Values are represented as fold change induction normalized to normal thyroid tissue expression of. SCD1. B) Immunohistochemistry of. SCD1 protein expression ...
In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific ...
John B. Gebhart, M.D.. Surgeon; Gynecologist; Urogynecologist. Rochester, MN ...
... B, Frasco P, Aqel B, Mathur AK, Moss A, Reddy KS. Liver transplant outcomes using late allocation grafts. Liver Transpl. 2023 Dec 1; 29 (12):1323-1329 Epub ...
Belantamab mafodotin (GSK2857916) is an antibody-drug conjugate (ADC) containing humanized anti- B-cell maturation antigen (BCMA) monoclonal antibody (mAb).
active Hepatitis B or Hepatitis C. Antiviral prophylaxis for chronic Hepatitis B virus infection may be used at the discretion of the investigator.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.